medigraphic.com

2005, Number 1

<< Back Next >>

Rev Med Inst Mex Seguro Soc 2005; 43 (1)

Age of onset of different malignant tumors in childhood

Mejía AJM, Flores AH, Juárez MI, Vázquez LJ, Games EJ, Pérez SML, Ortega ÁMC, Rendón MME, Fajardo GA

Language: Spanish
References: 95
Page: 25-37
PDF size: 367.28 Kb.


ABSTRACT

Objective: To identify the main age of onset of different malignant tumors in childhood and to describe the distribution of the different tumors in each pediatric age group.
Material and Methods: Descriptive survey was used. We reviewed the files of six Mexico City hospitals from 1980 to 1992. We included 4595 cases divided into 13 types of cancer. Peak age was defined when in that year we encountered a frequency equal to or below 10 % of the cases.
Results: Peak ages for hepatic, sympathetic nervous system, germ cell tumors, retinoblastoma and rhabdomyosarcoma were between 2 and 3 years of age. Wilms’ tumor appeared between the first and fourth years; central nervous system tumors between 4 and 5 years; acute lymphoblastic leukemia between 2 and 4 years; non-Hodgkin’s lymphomas between 3 and 6 years; Hodgkin’s disease between 4 and 8 years; bone tumors between 10 and 14 years. In acute myeloid leukemia and carcinomas no age peak was found.
Conclusions: Lymphomas present an age peak different from that reported in developed countries. In neonates and infants, the most frequent tumor was retinoblastoma.


REFERENCES

  1. 1. Birch JM, Blair V. The epidemiology of infant cancers. Br J Cancer 1992;66(Suppl 18):2-4.

  2. 2. Bernard JL, Bernard-Couteret E, Coste D, Thyss A, Sceiner C, Perrimond H, et al. Childhood cancer incidence in the South East of France. Eur J Cancer 1993;29a:2284-2291.

  3. 3. Alert SJ, Lonchong RM. Incidencia y mortalidad de las neoplasias malignas de los niños en Cuba. Rev Cub Pediatr 1979;51:311-340.

  4. 4. Roush SW, Krischer JP, Pollock NC, Cox MW, Pollock BH, Bayer J. The incidence of pediatric cancer in Florida, 1981 to 1986. Cancer 1992;69: 2212-2219.

  5. 5. Smith MA, Gloecker RL. Childhood cancer: incidence, survival, and mortality. En: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology. Philadelphia: Lippincott Williams and Wilkins Publishers; 2002. p. 1-12.

  6. 6. Schellong G. What’s new in pediatric oncology? Epidemiology, treatment principles and prognosis in childhood malignancies. Pathol Res Pract 1985; 178:425-428.

  7. 7. Miller RW, Myers MH. Age distribution of epithelial and non-epithelial cancers. Lancet 1983;2:1250.

  8. 8. Draper GJ, Kroll ME, Stiller CA. Childhood cancer. Cancer Surv 1994;19/20:493-517.

  9. 9. William AO. Tumors of childhood in Ibadan, Nigeria. Cancer 1975;36:370-378.

  10. Nully-Brown P, Hertz H, Olsen JH, Yssing M, Scheibel E, Jensen OM. Incidence of childhood cancer in Denmark 1943-1984. Int J Epidemiol 1989;18:546-555.

  11. Kaatsch P, Haaf G, Michaelis J. Childhood malig-nancies in Germany. Methods and results of a nationwide registry. Eur J Cancer 1995;31A:993-999.

  12. Young JI, Gloeckler RL, Silverberg E, Horm JW, Miller R. Cancer incidence, survival, and mortality for children younger than age 15 years. Cancer 1986;58:598-602.

  13. Fajardo-Gutiérrez A, Mejía-Aranguré M, Gómez-Delgado A, Mendoza-Sánchez H, Garduño-Espinosa J, Martínez-García MC. Epidemiología de las neoplasias malignas en niños residentes del Distrito Federal (1982-1991). Bol Med Hosp Infant Mex 1995;52:513-522.

  14. Parkin DM, Stiller CA, Draper GJ, Beiber CA. The international incidence of childhood cancer. Int J Cancer 1988;42:511-520.

  15. Greenberg RS, Shuster JL. Epidemiology of cancer in children. Epidemiologic Review 1985;7:22-48.

  16. Miller RW, Young JL, Novakovic B. Childhood cancer. Cancer 1995;75(Suppl):395-405.

  17. Drut R, Hernández A, Pollono D. Incidence of childhood cancer in La Plata, Argentina, 1977-1987. Int J Cancer 1990;45:1045-1047.

  18. Parkes SE, Muir KR, Sothern L, Cameron AH, Darbyshire PJ, Stevens MC. Neonatal tumors: a thirty-year population-based study. Med Pediatr Oncol 1994;22:309-317.

  19. Rothman KJ. Epidemiology. An introduction. New York: Oxford University Press; 2002. p. 94-112.

  20. Stiller CA. Descriptive epidemiology of childhood leukemia and lymphoma in Great Britain. Leuk Res 1985;9:671-674.

  21. Weinberg AG, Finegold ML. Primary hepatic tumors of childhood. Hum Pathol 1983;14:512-537.

  22. Exelby PR, Filler RM, Grosfeld JL. Liver tumors in children in the particular reference to hepato-blastoma and hepatocellular carcinoma: American Academy of Pediatrics Surgical Section Survey-1974. J Pediatr Surg 1975;10:329-337.

  23. Salas-Martínez M. Neoplasias malignas en los niños. México: Interamericana McGraw-Hill; 1988. p. 324-337.

  24. Fraumeni JF, Miller RW, Hill JA. Primary carcinoma of the liver in childhood: An epidemiology study. J Natl Cancer Inst 1968;40:1087-1099.

  25. Mahour GH, Wogu GU, Siegel SE, Isaacs H. Im-proved survival in infants and children with primary malignant liver tumors. Am J Surg 1983; 146:236-240.

  26. Tomlinson GE, Finegold MJ. Tumors of the liver. En: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology. Philadelphia: Lippincott Williams and Wilkins Publishers; 2002. p. 847-864.

  27. Brodeur GM, Maris JM. Neuroblastoma. En: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology. Philadelphia: Lippincott Williams and Wilkins Publishers; 2002. p. 895-938.

  28. Stiller CA. Trends in neuroblastoma in Great Britain: Incidence and mortality. Eur J Cancer 1993;29:1008-1012.

  29. Davis S, Rogers MAM, Pendergrass TW. The inci-dence and epidemiologic characteristics of neuro-blastoma in the United States. Am J Epidemiol 1987; 1063-1074.

  30. Cowell JK. Genetics of pediatric solid tumours. Br Med Bull 1994;50:600-623.

  31. Young JL, Ries LG, Silverberg E, Horm JW, Miller RW. Cancer incidence, survival, and mortality for children younger than age 15 years. Cancer 1986; 58:598-602.

  32. Tamboli A, Podgor MJ, Horm JW. The incidence of retinoblastoma in the United States: 1974 through 1985. Arch Ophthalmol 1990;108:128-132.

  33. Devesa SS. The incidence of retinoblastoma. Am J Ophthalmol 1975;80:263-265.

  34. Francois J, Matton MT, De-Bie S, Tanaka Y, Vandenbulcke D. Genesis and genetics of retino-blastoma. Ophthalmologica Basel 1975;170:405-425.

  35. Sanders BM, Draper GJ, Kingston JE. Retino-blastoma in Great Britain 1969-80: incidence, treat-ment, and survival. Br J Ophtalmol 1988; 72:576-583.

  36. Schultz KR, Ranade S, Neglia JP, Ravindranath Y. An increased relative frequency of retinoblastoma at a rural regional referral hospital in Miraj, Maharashtra, India. Cancer 1993;72:282-286.

  37. Bernstein L, Smith MA, Liu L, Deapen D, Friedman DL. Germ cell, trophoblastic and other gonadal neoplasms. En: Ries LAG, Mith MA, Gurney JG, Linet M, Tamra T, Young JL, Bunin GR, editors. Cancer incidence and survival among children and adolescents: United States SEER program 1975-1995, National Cancer Institute, SEER program. Bethesta, MD:NIH Pub. No. 99-4649, 1999:125-137.

  38. Miller RW, Dalacer NA. Fatal rabdomyosarcoma among children in the United States, 1960-69. Cancer 1974;34:1897-1900.

  39. Sharp L, Cotton S, Little J. Descriptive epidemiology. En: Little J, editor. Epidemiology of childhood cancer. Lyon, France: IARC Scientific Publications No. 149, 1999. p. 10-66.

  40. Stiller CA, Parkin DM. International variations in the incidence of childhood renal tumors. Br J Cancer 1990;62:1026-1030.

  41. Scharnhorst V, Van der Eb AJ, Jochemsen AG. WT1 proteins: functions in growth and differentiation. Gene 2001;273:141-161.

  42. Breslow NE, Beckwith BJ. Epidemiological features of Wilms’ tumor: Results of the National Wilms’ Tumor Study. J Natl Cancer Inst 1982; 68:429-436.

  43. Breslow N, Olshan A, Beckwith JB, Green DM. Epidemiology of Wilms tumor. Med Pediatr Oncol 1993; 21:172-181.

  44. Pastore G, Carli M, Lemerle J, Tournade MF, Voute PA, Rey A, et al. Epidemiological features of Wilms’ tumor: Results of studies by the International Society of Pediatric Oncology (SIOP). Med Pediatr Oncol 1988;16:7-11.

  45. Delahunt B, Bethwaite PB, Nacey JN, Lewis ME, Fraser J. Wilms’ tumor in New Zealand 1960-1986. Br J Urol 1992;70:663-668.

  46. Breslow N, Beckwith JB, Ciol M, Sharples K. Age distribution of Wilms’ tumor: Report from the National Wilms’ Tumor Study. Cancer Res 1988;48: 1653-1657.

  47. National Wilms’ Tumor Study Committee. Wilms’ tumor: status report, 1990. J Clin Oncol 1991;9:877-887.

  48. Teppo L, Salonen T, Hakulinen T. Incidence of childhood cancer in Finland. J Natl Cancer Inst 1975; 55:1065-1067.

  49. Ericcson JLE, Karnström L, Mattsson B. Childhood cancer in Sweden, 1958-1974. I. Incidence and mortality. Acta Paediatr Scand 1978;67:425-432.

  50. Stiller CA, Nectoux J. International incidence of childhood brain and spinal tumours. Int J Epidemiol 1994; 23:458-464.

  51. De-la-Torre ML, Ridaura SC, Reyes MM, Rueda FF. Central nervous system tumors in Mexican children. Child’s Nerv Sist 1993;9:260-265.

  52. Schoenberg BS, Schoenberg DG, Christine BW, Gómez MR. The epidemiology of primary intra-cranial neoplasms of childhood: A population study. Mayo Clin Proc 1976; 51:51-56.

  53. Greaves MF, Colman SM, Beard MEJ, Bradstock K, Cabrera ME, Chen PM, et al. Geographical distribution of acute lymphoblastic leukemia subtypes: Second report of the collaborative group study. Leukemia 1993;7:27-34.

  54. Ramot B, Magrath I. Hypothesis: the environment is a major determinant of the immunological sub-type of lymphoma and acute lymphoblastic leukemia in children. Br J Haematol 1982; 52:183-189.

  55. Pratt JA, Velez R, Brender JD, Manton KG. Racial differences in acute lymphoblastic leukemia mortality and incidence trends. J Clin Epidemiol 1988;41:367-371.

  56. Reynolds T. Causes of childhood leukemia beginning to emerge. J Natl Cancer Inst 1998;90:8-10.

  57. Fraumeni JF, Miller RW. Epidemiology of human leukemia: recent observations. J Natl Cancer Inst 1967; 38:593-605.

  58. Taylor GM, Robinson MD, Binchy A, Birch JM, Stevens RF, Jones PM, et al. Preliminary evidence of an association between HLA-DPB1*0201 and childhood common acute lymphoblastic leukemia supports an infectious etiology. Leukemia 1995; 9:440-443.

  59. Kinlen LJ. Epidemiological evidence for an infective cause of childhood leukaemia: Comparison of a Scottish new town with nuclear reprocessing sites in Britain. Lancet 1988;10:1323-1327.

  60. Magrath IT. Malignant non-Hodgkin’s lymphomas in children. En: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology. Philadelphia: Lippincott Williams and Wilkins Publishers; 2002. p. 661-706.

  61. Márky I, Schmiegelow K, Perkkiö M, Jónssson OG, Storm-Mathiesen I, Gustafsson G, et al. Childhood non-Hodgkin’s lymphoma in the five Nordic countries. A five-year population-based study from the Nordic Society of Pediatric Hematology and Oncology. J Pediatr Hematol Oncol 1995;17:163-166.

  62. Franssila KO, Heiskala MK, Rapola J. Non-Hodgkin’s lymphomas in childhood. A clinico-pathologic and epidemiologic study in Finland. Cancer 1987; 59:1837-1846.

  63. Magrath IT. African Burkitt’s lymphoma. History, biology, clinical features and treatment. Am J Pediatr Hematol Oncol 1991;13:222-246.

  64. Weisenburger DD. Epidemiology of non-Hodgkin’s lymphoma: recent findings regarding an emerging epidemic. Ann Oncol 1994; 5(Suppl 1):19-24.

  65. Grufferman S, Delzell E. Epidemiology of Hodgkin’s disease. Epidemiol Rev 1984;6:76-106.

  66. Hudson MM, Donaldson SS. Hodgkin’s disease. En: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology. Philadelphia: Lippincott Williams and Wilkins Publishers; 2002. p. 637-660.

  67. Spitz MR, Sider JG, Johnson CC, Butler JJ, Pollack ES, Newell GR. Ethnic patterns of Hodgkin’s disease incidence among children and adolescents in the United States, 1973-82. J Natl Cancer Inst 1986;76: 235-239.

  68. Percy CL, Smith MA, Linet M, Gloeckler Ries LA, Friedman DL. Lymphomas and reticuloendothelial neoplasms. En: Ries LAG, Mith MA, Gurney JG, Linet M, Tamra T, Young JL y Bunin GR, editors. Cancer incidence and survival among children and adolescents: United States SEER program 1975-1995, National Cancer Institute, SEER program. Bethesta, MD:NIH Pub. No. 99-4649, 1999. p. 35- 49.

  69. Norris DG, Burgert EO, Cooper HA, Harrison EG. Hodgkin’s disease in childhood. Cancer 1975; 36:2109-2120.

  70. Medeiros LJ, Greiner TC. Hodgkin’s disease. Cancer 1994;75:357-369.

  71. Armstrong AA, Alexander FE, Pinto Paes R, Morad NA, Gallagher A, Krajewski AS, et al. Association of Epstein-Barr virus with pediatric Hodgkin’s disease. Am J Pathol 1993;142:1683-1688.

  72. Sobrinho-Simöes MA, Areias MA. Relative high frequency of childhood Hodgkin’s disease in the North of Portugal. Cancer 1978;42:1952-1956.

  73. Gad-El-Mawla N, El-Deep BB, Abu-Gabal A, Abdel-Hadi S, Hamza MR, Zikri ZKH, et al. Pediatric Hodgkin’s disease in Egypt. Cancer 1983;52:1129-1131.

  74. Alexander E, Ricketts TJ, McKinney PA, Cartwright RA. Community lifestyle characteristics and inci-dence of Hodgkin’s disease in young people. Int J Cancer 1991; 48:10-14.

  75. Glaser SL. Reproductive factors in Hodgkin’s disease in women: a review. Am J Epidemiol 1994; 139:237-246.

  76. Ross JA, Davies SM, Potter JD, Robison LL. Epidemiology of childhood leukemia, with a focus on infants. Epidemiol Rev 1994;16:243-272.

  77. Golub TR and Arceci RJ. Acute myelogenous leukemia. En: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology. Philadelphia: Lippincott Williams and Wilkins Publishers; 2002. p. 545-589.

  78. Blair V, Birch JM. Patterns and temporal trends in the incidence of malignant disease in children: I. Leukemia and lymphoma. Eur J Cancer 1994;30A: 1490-1498.

  79. Fraumeni JF, Manning MD, Mitus WJ. Acute childhood leukemia: Epidemiologic study by cell type of 1263 cases at the Children’s Cancer Research Foundation in Boston, 1947-65. J Natl Cancer Inst 1971;46:461-470.

  80. Westergaard T, Andersen PK, Pedersen JB, Olsen JH, Frisch M, Sörensen HT, et al. Birth charac-teristics, sibling patterns, and acute leukemia risk in childhood: A population-based cohort study. J Natl Cancer Inst 1997;89:939-947.

  81. Bhatia S, Neglia JP. Epidemiology of childhood acute myelogenous leukemia. J Pediatr Hematol Oncol 1995;17:94-100.

  82. Stiller CA. International variations in the incidence of childhood carcinomas. Cancer Epidemiol Biomarkers Prev 1994;3:305-310.

  83. Koch CA, Pacak K, Chrousos GP. Endocrine tumors. En: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology. Philadelphia: Lippincott Williams and Wilkins Publishers; 2002. p. 1115-1148.

  84. Parkin DM, Stiller CA, Nectoux J. International variations in the incidence of childhood bone tumours. Int J Cancer 1993;53:371-376.

  85. Homa DM, Sowers MR, Scheartz AG. Incidence and survival rates of children and young adults with osteogenic sarcoma. Cancer 1991;67:2219-2223.

  86. Gurney JG, Swensen AR, Bulterys M. Malignant bone tumors. En: Ries LAG, Mith MA, Gurney JG, Linet M, Tamra T, Young JL y Bunin GR, editors. Cancer incidence and survival among children and adolescents: United States SEER Program 1975-1995, National Cancer Institute, SEER Program. Bethesta, MD:NIH Pub. No. 99-4649, 1999. p. 99- 110.

  87. Buckley JD, Pendergrass TW, Bucley CM, Pritchard DJ, Nesbit ME, Provisor AJ, et al. Epidemiology of osteosarcoma and Ewing’s sarcoma in childhood. Cancer 1998; 83:1440-1448.

  88. Link MP, Gebhardt MC and Meyers PA. Osteo-sarcoma. En: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology. Philadelphia: Lippincott Williams and Wilkins Publishers; 2002. p. 1051-1089.

  89. Little J. Genetic factors and familial aggregation. En: Epidemiology of childhood cancer. Lyon, France: IARC Scientific Publications No. 149, 1999. p. 67-89.

  90. Lonardo F, Ueda T, Huvos AG, Healey J, Ladanyi M. p53 and MDM2 alterations in osteosarcomas. Correlation with clinicopathologic features and proliferative rate. Cancer 1997;79:1541-1547.

  91. Isaacs H. Congenital and neonatal malignant tumors. A 28-year experience at children’s hospital of Los Angeles. Am J Pediatr Hematol Oncol 1987;9:121-129.

  92. Laconi E, Pani P, Farber E. The resistance phenotype in the development and treatment and treatment of cancer. Lancet Oncol 2000; 1:235-241.

  93. Liotta LA, Kohn EC. The microenvironment of the tumour-host interface. Nature 2001; 411: 375-379.

  94. Morris JA. The age incidence of childhood acute lymphoblastic leukemia. Medical Hypotheses 1991;35:4-10

  95. Greaves M. Molecular genetics, natural history and the demise of childhood leukaemia. Eur J Cancer 1999; 35:1941-1953.




2020     |     www.medigraphic.com